Patent classifications
C07D207/48
SULFINYLAMINOBENZAMIDE AND SULFONYLAMINOBENZAMIDE DERIVATIVES
Provided is a compound of Formula (I):
##STR00001## wherein the variable groups are defined herein.
PYRROLIC AMIDE COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF
The present invention discloses a pyrrolic amide compound shown as a formula I, or crystal forms thereof, and pharmaceutically acceptable salts, hydrates or solvates, wherein R.sub.1 is selected from hydrogen, hydroxyl, cyano, halogen, carboxyl, C.sub.1-C.sub.6 alkyl and the like; R.sub.2 is selected from hydrogen, hydroxyl, cyano, halogen and the like; R.sub.3 is selected from hydroxyl and the like; X is selected from
##STR00001##
group, m is equal to 0, 1, 2 or 3, and n is equal to 0, 1 or 2. The novel compound shown as the formular I provided by the present invention has high deacetylase inhibitory viability; and meanwhile, a method for preparing the novel compound in the present invention has the advantages of fewer steps, simple and convenient operation, safety, environment friendliness, high yield and the like and is very suitable for industrial application.
##STR00002##
PYRROLIC AMIDE COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF
The present invention discloses a pyrrolic amide compound shown as a formula I, or crystal forms thereof, and pharmaceutically acceptable salts, hydrates or solvates, wherein R.sub.1 is selected from hydrogen, hydroxyl, cyano, halogen, carboxyl, C.sub.1-C.sub.6 alkyl and the like; R.sub.2 is selected from hydrogen, hydroxyl, cyano, halogen and the like; R.sub.3 is selected from hydroxyl and the like; X is selected from
##STR00001##
group, m is equal to 0, 1, 2 or 3, and n is equal to 0, 1 or 2. The novel compound shown as the formular I provided by the present invention has high deacetylase inhibitory viability; and meanwhile, a method for preparing the novel compound in the present invention has the advantages of fewer steps, simple and convenient operation, safety, environment friendliness, high yield and the like and is very suitable for industrial application.
##STR00002##
Thionyl tetrafluoride modified compounds and uses
Thionyl tetrafluoride gas reacts efficiently with primary amines to form reactive iminosulfur oxydifluoride compounds. These dual S.sup.VI—F loaded iminosulfur oxydifluoride compounds, in turn, readily react with secondary amines or aryloxy silyl ethers (ArO—SiR.sub.3), yielding the corresponding fused heteroatom-linked substrates. Iminosulfur oxyfluoride polymers also are provided by disclosed methods.
Thionyl tetrafluoride modified compounds and uses
Thionyl tetrafluoride gas reacts efficiently with primary amines to form reactive iminosulfur oxydifluoride compounds. These dual S.sup.VI—F loaded iminosulfur oxydifluoride compounds, in turn, readily react with secondary amines or aryloxy silyl ethers (ArO—SiR.sub.3), yielding the corresponding fused heteroatom-linked substrates. Iminosulfur oxyfluoride polymers also are provided by disclosed methods.
Compounds and uses thereof for the modulation of hemoglobin
Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
Compounds and uses thereof for the modulation of hemoglobin
Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
COMPOUNDS CONTAINING A SULFONIC GROUP AS KAT INHIBITORS
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
##STR00001##
COMPOUNDS CONTAINING A SULFONIC GROUP AS KAT INHIBITORS
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
##STR00001##
Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulators
The invention is concerned with the compounds of formula I or II: ##STR00001##
and salts thereof. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I or II as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.